Procedural Advantages of a Novel Drug-Eluting Coronary Stent

This study sought to compare procedural performance of a new coronary stent generation, that is already available in Germany, with hitherto established current drug-eluting stents.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

CAD for PCI, consecutive patients

Exclusion criteria

Age under 18
Bare Metal Stents or Scaffolds

Treatment and study plan

Synergy Stent

Device

Patients with narrowed coronary artery disease qualifying for PCI were treated with Synergy stent implantation.

Other names: Synergy Coronary Stent

Currently common drug-eluting stent (DES)

Device

Patients with narrowed coronary artery disease qualifying for PCI were treated with DES implantation (Xience Prime, Resolute Integrity, Promus Element Plus)

Other names: DES including Xience Prime, Resolute Integrity, Promus Element Plus.

Primary outcomes

In-hospital major cardiac adverse events

Time frame: One week post-procedure

In-hospital major cardiac adverse events were collected up to one week after procedure throughout the in-patients stay

Sponsors and collaborators

Lead sponsor

University Hospital Heidelberg

Other

Registry information

Official study title

Procedural Advantages of a Novel Drug-Eluting Coronary Stent With Ultra-Thin Struts and Bioabsorbable Abluminal Polymer Coating in an All-Comers Registry

Important dates

Study start: 2015
Primary completion: 2015
Study completion: 2016
First posted: Aug 26, 2016
Registry last updated: Aug 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed